Target Attainment and Pharmacokinetics of Antimicrobials in Non-critically Ill Surgery Patients (TAPAS)
NCT03120663 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2017-04-20
Summary
In this prospective observational study, the investigators want to document pharmacokinetic/pharmacodynamic (PK/PD) target attainment of frequently used antimicrobials in an adult non critically ill surgery population (abdominal surgery, traumatology and septic orthopedic surgery). Furthermore, the investigators want to identify risk factors for not attaining predefined PK/PD targets.
The antibiotics of interest are amoxicillin(-clavulanic acid), flucloxacillin, piperacillin-tazobactam, meropenem and clindamycin.
Conditions
- Surgery
Interventions
- DRUG
-
amoxicillin-clavulanic acid
During one dosing interval at steady state of the involved antimicrobials (ABs), AB plasma concentrations will be determined. Besides, the measured creatinine clearance based on an 8-hour urinary collection (CrCl8h) will be used as the primary method for determining kidney function. Based on these values, CrCl8h will be calculated according to the standard formula and normalized to a body surface area (BSA) of 1.73m² .
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Peter Declercq, PharmD · Universitaire Ziekenhuizen KU Leuven
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2018-09-30
- Completion
- 2018-09-30
Countries
- Belgium
Study Locations
More Related Trials
-
Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children
NCT06929702 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study
NCT05447559 ·Status: RECRUITING ·Phase: PHASE4
-
Antibiotic Dosing in Pediatric Intensive Care
NCT02456974 ·Status: RECRUITING
-
Pharmacokinetics of Piperacillin/Tazobactam in Patients Treated by Continuous Renal Replacement Therapy
NCT00703144 ·Status: COMPLETED ·Phase: PHASE4
-
Prophylaxis Of Wound Infections- Antibiotics in Renal Donation
NCT02089568 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Carbapenem Antibiotics in Obese Patients.
NCT01407965 ·Status: COMPLETED ·Phase: PHASE4
-
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
NCT06426836 ·Status: RECRUITING ·Phase: NA
-
The Expected Advantage of Administering Prophylactic Antibiotics Using Target- Concentration Controlled Infusion
NCT05253339 ·Status: COMPLETED ·Phase: NA
-
Population Pharmacokinetics of Antibiotics in Critically Ill Children (POPSICLE)
NCT03248349 ·Status: UNKNOWN
-
Pharmacokinetics of Amikacin and Cefuroxime in Critically Ill Patients.
NCT04470973 ·Status: UNKNOWN
-
Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)
NCT00663403 ·Status: COMPLETED ·Phase: PHASE4
-
Antibiotic PRophylAxis Based on infeCTIve Risk in Cardiac Implantable Electronic Device
NCT04736979 ·Status: COMPLETED
-
Pharmacokinetics and Pleural Fluid Penetration of Amoxicillin and Clavulanic Acid in Patients With Pleural Infections
NCT04350502 ·Status: COMPLETED ·Phase: NA
-
Local Antibiotics for Breast Implants
NCT04731025 ·Status: RECRUITING ·Phase: PHASE3
-
Daptomycin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-venous Hemodiafiltration, a Dose Finding Study
NCT01212432 ·Status: UNKNOWN ·Phase: PHASE2
-
The Role of Guideline-adherent Perioperative Antibiotic Administration and the Risk of Surgical Site Infections After Non-cardiac Surgery.
NCT03982810 ·Status: WITHDRAWN
-
Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients
NCT03557840 ·Status: UNKNOWN ·Phase: NA
-
Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration
NCT01171547 ·Status: UNKNOWN ·Phase: PHASE2
-
Pediatric Cardiac Surgery Comparing Short 24-hour Antibiotic Prophylaxis to Extended Antibiotic Prophylaxis
NCT05612542 ·Status: COMPLETED
-
Improving Perioperative Antimicrobial Prophylaxis by the Use of a Computerized Decision Support System
NCT03456635 ·Status: SUSPENDED ·Phase: NA
-
Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure
NCT02142075 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital
NCT05862402 ·Status: UNKNOWN ·Phase: PHASE4
-
To Investigate the Multiple Dose Safety, Tolerability and Pharmacokinetics of WCK 4282 (FEP-TAZ)
NCT03622008 ·Status: COMPLETED ·Phase: PHASE1
-
LocalVancomycinPowderToPreventPeriprostheticJointInfection.
NCT05697965 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous Infusion
NCT01198925 ·Status: COMPLETED ·Phase: PHASE4